Anti-PRO 1313 antibodies

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S388100, C530S388150, C530S387700, C530S387100, C530S391100, C530S391300

Reexamination Certificate

active

10242095

ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: WO 01/62918 (2001-08-01), None
patent: WO 01/75067 (2001-10-01), None
Database Search, DNA sequence alignments [BLASTN 2.1.2 (Jan. 8, 2002), NCBI].
Database Search, protein sequence alignments [BLASTP 2.2.2 (Jan. 8, 2002), NCBI].
Klein et al., “Selection for genes encoding secreted proteins and receptors”Proc. Nat. Acad. Sci. USA93:7108-7113 (1996).
Genbank, Accession No. P—ABK69975, WO 200224888-A2, Pub Date: Mar. 28, 2002, Baker et al.
Genbank, Accession No. P—AAC91566, WO 200073348-A2, Pub Date: Dec. 7, 2000, Baker et al.
Genbank, Accession No. P—AAA77681, WO 200032221-A2, Pub Date: Jun. 8, 2000, Ashkenazi et al.
Genbank, Accession No. P—AAC85948, WO 200140464-A1, Pub Date: Jun. 7, 2000, Ashkenazi et al.
Genbank, Accession No. AX055712, WO 0073348-A 27, Pub Date: Dec. 7, 2000, Baker et al.
Genbank, Accession No. AX150811, WO 0140464-A 7, Pub date: Jun. 7, 2001, Ashkenzaki et al.
Genbank, Accession No. BC037287, Proc. Natl. Acad. Sci., USA 99, (26), 16899-16903 (2002), Strausberg et al.
Genbank, Accession No. MGC33214, Proc. Natl. Acad. Sci., USA 99, (26), 16899-16903 (2002), Strausberg et al.
Genbank, Accession No. P—AAS63166, WO 200162918-A2, Pub Date: Aug. 30, 2001, Panzer et al.
Genbank, Accession No. P—ABN99385, WO 200226982-A2, Pub Date: Apr. 4, 2002, Yue et al.
Dayhoff, Accession No. XM—087662, Direct Submission, Submitted Jul. 31, 2002, NCBI Annotation Project.
Dayhoff, Accession No. P—ABG34044, WO 200224888-A2, Pub Date: Mar. 28, 2002, Baker et al.
Dayhoff, Accession No. P—AAB50964, WO200073348-A2, Pub Date: Dec. 7, 2000, Baker et al.
Dayhoff, Accession No. P—AAB47290, WO200140464-A1, Pub Date: Jun. 7, 2001, Ashkenazi et al.
Dayhoff, Accession No. P—AAB24431, WO 200032221-A, Pub Date: Jun. 8, 2000, Ashkenazi et al.
Dayhoff, Accession No. P—ABP43502, WO 200226982-A2, Pub Date: Apr. 4, 2002, Yue et al.
Dayhoff, Accession No. P—AAU69453, WO 200162918-A2, Pub date: Aug. 30, 2001, Panzer et al.
Dayhoff, AAH37287.1, Natl. Inst. Health, Direct Submission, Submitted Sep. 3, 2002.
Dayhoff, NP—699185.1, Genome Research, 13 (10), pp. 2265-2270 (2003), Clark et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Anti-PRO 1313 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-PRO 1313 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-PRO 1313 antibodies will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3869575

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.